---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-25-000048"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2025-03-14T23:59:59+00:00"
generated_at: "2026-05-24T18:04:11.544291+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Pacira BioSciences adopts majority voting standard for uncontested director elections

## Summary
- Board approved Third Amended and Restated Bylaws effective March 12, 2025.
- Majority voting applies to uncontested director elections; plurality retained for contested.
- No other changes were made to the prior bylaws.
- Change is effective immediately upon approval.

## SEC filing metadata
- accession: 0001396814-25-000048
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2025-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000048/0001396814-25-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000048/pcrx-20250312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-25-000048
- JSON: https://secwatch.observer/filing/0001396814-25-000048.json
- Plain text: https://secwatch.observer/filing/0001396814-25-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.